Echo IQ is trading at A$0.57, up 5.50% in the supplied September 30, 2026 price context; no specific catalyst was identified.
- ASX announcement listings show no new company announcement dated September 30. The latest listed update, on September 17, concerned work to address FDA issues for EchoSolv HF.
- The earlier FDA setback and subsequent regulatory-pathway update provide recent background, but neither establishes a cause for this move.
- Supplied major-index figures are flat, so the evidence does not point to a broad-market explanation.